Actively Recruiting
Acceptability Pilot of Auricular Vagus Nerve Stimulation to Prevent Recurrence of Non-suicidal Self-Injury in Adolescents
Led by Centre Hospitalier Régional Metz-Thionville · Updated on 2026-10-22
22
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are exploring the use of transcutaneous auricular vagal nerve stimulation taVNS to help adolescents with non-suicidal self-injury NSSI disorder, a behavior characterized by intentional self-harm without suicidal intent. NSSI is prevalent among adolescents, especially following the COVID-19 crisis, and current drug treatments lack solid scientific support. The study aims to see if taVNS, which may improve stress regulation through the hypothalamic-pituitary axis by stimulating the vagus nerve, can be accepted and used regularly by adolescents. Participants will use a device called TENS ECO PLUS along with a vagus nerve ear electrode to deliver taVNS for 10 minutes twice daily or 20 minutes once daily over eight consecutive weeks. The treatment period is from week 2 to week 10 after inclusion, with follow-up continuing until week 22. Researchers will assess how well adolescents adhere to this at-home treatment and monitor any changes in the frequency of self-injury, anxiety, depression, and side effects. During the study, participants will be monitored for treatment adherence, frequency of self-injury episodes weekly from two weeks before treatment through 20 weeks after, and psychological symptoms at several time points. Safety and patient experiences with taVNS will also be evaluated. The total participation lasts approximately 22 weeks, allowing detailed observation of treatment effects and user adherence.
CONDITIONS
Brief Title
Pilot Study on the Acceptability of Auricular Vagus Nerve Neurostimulation in Adolescents
Research Team
J
Justine GRIGORCEA, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here